Remark on suv of pet - ct in small cell lung cancer

Bui Anh Thang1, Mai Trong Khoa
1 Nuclear Medicine Center Bach Mai Hospital

Main Article Content

Abstract

SUMMARY


Objective: Determine the ability of PET/CT in
detection of metastasis lesion in patient with small cell lung cancer and the correlation between FDG with size, stage of disease in patients with small cell lung cancer.
Subjects and methods: 24 patients were diagnosed of lung cancer by PET/CT and the histopathological finding was small cell lung cancer at Oncology and Nuclear Medicine Center of Bach Mai Hospital, from August 2010
to October 2015.
Results: PET/CT could detect the metastasis lesion at: mediastinal lymph nodes 54.2%, neck lymph nodes 37.5%, abdominal lymph nodes 12.5%, lung metastases 25%, bone 16.7%, liver and pancreas 4.2%. FDG uptakeis fairly wellcorrelated with tumor size (r = 0.446, p < 0.05). There is no correlation between FDG uptake with the stage of cancer. Conclusion: PET/CT plays an important role in diagnosis of small cel lung cancer.

Article Details

References

TÀI LIỆU THAM KHẢO
1. American Cancer Society (2006), Cancer Facts and Figures, www.cancer.org.
2. Sørensen M, Pijls-Johannesma M, Felip E; ESMO Guidelines Working Group (2010), Smallcell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 21 Suppl 5, pp. 120-125
3. Chua YJ, Steer C, Yip D (2004), Recent advances in management of small-cell lung cancer. Cancer Treat Rev, 30:521-43.
4. Usuda K, Saito Y, Sagawa M, Sato M, Kanma K, Takahashi S, et al (1994). Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer; 74:2239-44.
5. Park MR, Park YH, Choi JW (2014), Progression-free survival: an important prognostic marker for long-term survival of small cell lung cancer, Tuberc Respir Dis (Seoul), 76(5): 218-25.
6. FNCA (2010), Workshop on Cyclotron and